IIPR Innovative Industrial Properties | $70.71
+0.5% | 12/23/2024 | Downgraded by | BTIG Research | Analyst T. Catherwood | Buy -> Neutral | | N/A | View details for BTIG Research rating of Innovative Industrial Properties (NYSE:IIPR) on 12/23/2024 |
IREN Iris Energy | $11.34
-4.0% | 12/20/2024 | Initiated by | BTIG Research | Analyst G. Lewis | Buy | $33.00 | N/A | View details for BTIG Research rating of Iris Energy (NASDAQ:IREN) on 12/20/2024 |
LEN Lennar | $138.64
+0.5% | 12/20/2024 | Downgraded by | BTIG Research | Analyst C. Reichardt | Buy -> Neutral | | N/A | View details for BTIG Research rating of Lennar (NYSE:LEN) on 12/20/2024 |
FREY FREYR Battery | $3.03
+1.7% | 12/20/2024 | Upgraded by | BTIG Research | Analyst G. Lewis | Neutral -> Buy | $4.00 | N/A | View details for BTIG Research rating of FREYR Battery (NYSE:FREY) on 12/20/2024 |
AVTX Avalo Therapeutics | $9.09
+3.2% | 12/19/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $40.00 | N/A | View details for BTIG Research rating of Avalo Therapeutics (NASDAQ:AVTX) on 12/19/2024 |
RNAC Cartesian Therapeutics | $19.88
+7.6% | 12/19/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $42.00 | N/A | View details for BTIG Research rating of Cartesian Therapeutics (NASDAQ:RNAC) on 12/19/2024 |
|
BIRK Birkenstock | $60.24
+0.1% | 12/18/2024 | Target Raised by | BTIG Research | Analyst J. Stichter | Buy | $60.00 -> $70.00 | N/A | View details for BTIG Research rating of Birkenstock (NYSE:BIRK) on 12/18/2024 |
ADPT Adaptive Biotechnologies | $6.44
+0.8% | 12/18/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $8.00 -> $9.00 | N/A | View details for BTIG Research rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 12/18/2024 |
REAX Real Brokerage | $4.82
+0.6% | 12/18/2024 | Initiated by | BTIG Research | Analyst J. Fuller | Buy | $6.00 | N/A | View details for BTIG Research rating of Real Brokerage (NASDAQ:REAX) on 12/18/2024 |
GTLS Chart Industries | $195.62
+1.9% | 12/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $170.00 -> $210.00 | N/A | View details for BTIG Research rating of Chart Industries (NYSE:GTLS) on 12/16/2024 |
BE Bloom Energy | $24.33
| 12/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $20.00 -> $30.00 | N/A | View details for BTIG Research rating of Bloom Energy (NYSE:BE) on 12/16/2024 |
CORZ Core Scientific | $14.50
-3.1% | 12/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $19.00 -> $20.00 | N/A | View details for BTIG Research rating of Core Scientific (NASDAQ:CORZ) on 12/16/2024 |
GAMB Gambling.com Group | $14.44
+0.1% | 12/13/2024 | Target Raised by | BTIG Research | - | Buy | $13.00 -> $19.00 | N/A | View details for BTIG Research rating of Gambling.com Group (NASDAQ:GAMB) on 12/13/2024 |
ELVN Enliven Therapeutics | $22.71
-1.9% | 12/13/2024 | Initiated by | BTIG Research | Analyst J. Zelin | Buy | $42.00 | N/A | View details for BTIG Research rating of Enliven Therapeutics (NASDAQ:ELVN) on 12/13/2024 |
AXDX Accelerate Diagnostics | $1.11
+3.7% | 12/11/2024 | Upgraded by | BTIG Research | Analyst M. Massaro | Strong-Buy | | N/A | View details for BTIG Research rating of Accelerate Diagnostics (NASDAQ:AXDX) on 12/11/2024 |
GMED Globus Medical | $84.42
+1.1% | 12/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $87.00 -> $91.00 | N/A | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 12/12/2024 |
KROS Keros Therapeutics | $16.81
+0.6% | 12/12/2024 | Downgraded by | BTIG Research | Analyst J. Harrison | Buy -> Neutral | | N/A | View details for BTIG Research rating of Keros Therapeutics (NASDAQ:KROS) on 12/12/2024 |
AVDX AvidXchange | $10.51
+0.5% | 12/11/2024 | Initiated by | BTIG Research | Analyst A. Harte | Buy | $14.00 | N/A | View details for BTIG Research rating of AvidXchange (NASDAQ:AVDX) on 12/11/2024 |
NRIX Nurix Therapeutics | $19.93
+1.8% | 12/10/2024 | Initiated by | BTIG Research | Analyst J. Mukherjee | Buy | $35.00 | N/A | View details for BTIG Research rating of Nurix Therapeutics (NASDAQ:NRIX) on 12/10/2024 |
KYMR Kymera Therapeutics | $42.02
+2.9% | 12/10/2024 | Initiated by | BTIG Research | Analyst J. Mukherjee | Buy | $60.00 | N/A | View details for BTIG Research rating of Kymera Therapeutics (NASDAQ:KYMR) on 12/10/2024 |
ARVN Arvinas | $19.08
+1.9% | 12/10/2024 | Initiated by | BTIG Research | Analyst J. Mukherjee | Buy | $69.00 | N/A | View details for BTIG Research rating of Arvinas (NASDAQ:ARVN) on 12/10/2024 |
CARM Carisma Therapeutics | $0.44
+10.8% | 12/10/2024 | Downgraded by | BTIG Research | Analyst J. Zelin | Buy -> Neutral | | N/A | View details for BTIG Research rating of Carisma Therapeutics (NASDAQ:CARM) on 12/10/2024 |
ONIT Onity Group | $30.62
-0.9% | 12/9/2024 | Upgraded by | BTIG Research | Analyst E. Hagen | Neutral -> Buy | $40.00 | N/A | View details for BTIG Research rating of Onity Group (NYSE:ONIT) on 12/9/2024 |
OKTA Okta | $83.02
-0.2% | 12/4/2024 | Target Raised by | BTIG Research | - | Buy | $98.00 -> $110.00 | N/A | View details for BTIG Research rating of Okta (NASDAQ:OKTA) on 12/4/2024 |
JANX Janux Therapeutics | $55.17
-1.7% | 12/3/2024 | Target Raised by | BTIG Research | - | Buy | $82.00 -> $100.00 | N/A | View details for BTIG Research rating of Janux Therapeutics (NASDAQ:JANX) on 12/3/2024 |
EVH Evolent Health | $11.34
+0.6% | 12/3/2024 | Target Lowered by | BTIG Research | - | Buy | $36.00 -> $29.00 | N/A | View details for BTIG Research rating of Evolent Health (NYSE:EVH) on 12/3/2024 |
BV BrightView | $16.40
+1.8% | 12/2/2024 | Initiated by | BTIG Research | Analyst C. Reichardt | Buy | $22.00 | N/A | View details for BTIG Research rating of BrightView (NYSE:BV) on 12/2/2024 |
ANAB AnaptysBio | $13.74
-1.1% | 12/2/2024 | Downgraded by | BTIG Research | Analyst J. Harrison | Buy -> Neutral | | N/A | View details for BTIG Research rating of AnaptysBio (NASDAQ:ANAB) on 12/2/2024 |
OTLK Outlook Therapeutics | $1.70
+15.6% | 11/29/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $50.00 -> $9.00 | N/A | View details for BTIG Research rating of Outlook Therapeutics (NASDAQ:OTLK) on 11/29/2024 |
REG Regency Centers | $74.61
+0.1% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $72.00 -> $79.00 | N/A | View details for BTIG Research rating of Regency Centers (NASDAQ:REG) on 11/27/2024 |
CDP COPT Defense Properties | $31.46
+0.5% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $33.00 -> $38.00 | N/A | View details for BTIG Research rating of COPT Defense Properties (NYSE:CDP) on 11/27/2024 |
ADC Agree Realty | $70.81
-0.2% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $74.00 -> $78.00 | N/A | View details for BTIG Research rating of Agree Realty (NYSE:ADC) on 11/27/2024 |
ZS Zscaler | $187.63
+0.2% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $205.00 -> $238.00 | N/A | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 11/27/2024 |
PNST Pinstripes | $0.45
+0.9% | 11/27/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $4.00 -> $3.00 | N/A | View details for BTIG Research rating of Pinstripes (NYSE:PNST) on 11/27/2024 |
EMBC Embecta | $20.83
+2.7% | 11/27/2024 | Upgraded by | BTIG Research | Analyst M. Thibault | Neutral -> Buy | $26.00 | N/A | View details for BTIG Research rating of Embecta (NASDAQ:EMBC) on 11/27/2024 |
ALC Alcon | $86.30
+0.3% | 11/26/2024 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Strong-Buy -> Hold | | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 11/26/2024 |
ALEC Alector | $1.82
-1.6% | 11/26/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $16.00 -> $5.00 | N/A | View details for BTIG Research rating of Alector (NASDAQ:ALEC) on 11/26/2024 |
PSTX Poseida Therapeutics | $9.51
+0.2% | 11/26/2024 | Reiterated by | BTIG Research | Analyst J. Zelin | Buy -> Neutral | | N/A | View details for BTIG Research rating of Poseida Therapeutics (NASDAQ:PSTX) on 11/26/2024 |
ISRG Intuitive Surgical | $538.83
+0.3% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $535.00 -> $561.00 | N/A | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 11/26/2024 |
GKOS Glaukos | $152.67
+1.0% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $140.00 -> $149.00 | N/A | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 11/26/2024 |
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad) Elon Musk believes his new AI product will be worth an incredible $9 trillion.
But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. |
PEN Penumbra | $240.54
+0.1% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $232.00 -> $270.00 | N/A | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 11/26/2024 |
VCEL Vericel | $57.67
+0.6% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $56.00 -> $66.00 | N/A | View details for BTIG Research rating of Vericel (NASDAQ:VCEL) on 11/26/2024 |
EXAS Exact Sciences | $57.48
-1.1% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $65.00 -> $75.00 | N/A | View details for BTIG Research rating of Exact Sciences (NASDAQ:EXAS) on 11/26/2024 |
VVX V2X | $47.55
+0.3% | 11/25/2024 | Initiated by | BTIG Research | Analyst A. Madrid | Buy | $80.00 | N/A | View details for BTIG Research rating of V2X (NYSE:VVX) on 11/25/2024 |
PANW Palo Alto Networks | $188.50
-0.5% | 11/21/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $197.50 -> $207.00 | N/A | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 11/21/2024 |
MSTR MicroStrategy | $341.05
-4.8% | 11/21/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $290.00 -> $570.00 | N/A | View details for BTIG Research rating of MicroStrategy (NASDAQ:MSTR) on 11/21/2024 |
ACRS Aclaris Therapeutics | $2.92
+0.7% | 11/19/2024 | Upgraded by | BTIG Research | Analyst J. Harrison | Neutral -> Buy | $8.00 | N/A | View details for BTIG Research rating of Aclaris Therapeutics (NASDAQ:ACRS) on 11/19/2024 |
VYNE VYNE Therapeutics | $3.23
+8.8% | 11/18/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $8.00 | N/A | View details for BTIG Research rating of VYNE Therapeutics (NASDAQ:VYNE) on 11/18/2024 |
BE Bloom Energy | $24.33
| 11/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $16.00 -> $20.00 | N/A | View details for BTIG Research rating of Bloom Energy (NYSE:BE) on 11/15/2024 |
CIFR Cipher Mining | $5.26
-4.4% | 11/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $6.00 -> $9.00 | N/A | View details for BTIG Research rating of Cipher Mining (NASDAQ:CIFR) on 11/15/2024 |
CORZ Core Scientific | $14.50
-3.1% | 11/15/2024 | Target Raised by | BTIG Research | Analyst G. Lewis | Buy -> Buy | $15.00 -> $19.00 | N/A | View details for BTIG Research rating of Core Scientific (NASDAQ:CORZ) on 11/15/2024 |
HQY HealthEquity | $97.41
+1.8% | 11/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $110.00 -> $130.00 | N/A | View details for BTIG Research rating of HealthEquity (NASDAQ:HQY) on 11/14/2024 |
PLUG Plug Power | $2.38
-1.7% | 11/14/2024 | Downgraded by | BTIG Research | Analyst G. Lewis | Buy -> Neutral | | N/A | View details for BTIG Research rating of Plug Power (NASDAQ:PLUG) on 11/14/2024 |
ONON ON | $56.39
-0.1% | 11/13/2024 | Upgraded by | BTIG Research | Analyst J. Stichter | Neutral -> Buy | $64.00 | N/A | View details for BTIG Research rating of ON (NYSE:ONON) on 11/13/2024 |
ATLC Atlanticus | $59.35
+3.1% | 11/12/2024 | Target Raised by | BTIG Research | Analyst V. Caintic | Buy -> Buy | $45.00 -> $54.00 | N/A | View details for BTIG Research rating of Atlanticus (NASDAQ:ATLC) on 11/12/2024 |
VEL Velocity Financial | $19.46
+0.3% | 11/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $20.00 -> $23.00 | N/A | View details for BTIG Research rating of Velocity Financial (NYSE:VEL) on 11/12/2024 |
CCSI Consensus Cloud Solutions | $24.28
+3.0% | 11/11/2024 | Target Raised by | BTIG Research | Analyst D. Larsen | Buy -> Buy | $30.00 -> $32.00 | N/A | View details for BTIG Research rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 11/11/2024 |
FLUT Flutter Entertainment | $259.29
-0.8% | 11/11/2024 | Target Raised by | BTIG Research | Analyst C. Lampen | Buy -> Buy | $249.00 -> $305.00 | N/A | View details for BTIG Research rating of Flutter Entertainment (NYSE:FLUT) on 11/11/2024 |
UPST Upstart | $72.03
+5.1% | 11/11/2024 | Upgraded by | BTIG Research | Analyst V. Caintic | Sell -> Neutral | | N/A | View details for BTIG Research rating of Upstart (NASDAQ:UPST) on 11/11/2024 |
EXPE Expedia Group | $190.12
+0.2% | 11/8/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $175.00 -> $200.00 | N/A | View details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 11/8/2024 |
PODD Insulet | $265.68
+0.9% | 11/8/2024 | Target Raised by | BTIG Research | Analyst M. Thibault | Buy -> Buy | $260.00 -> $270.00 | N/A | View details for BTIG Research rating of Insulet (NASDAQ:PODD) on 11/8/2024 |
APP AppLovin | $346.73
+1.4% | 11/7/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $202.00 -> $291.00 | N/A | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 11/7/2024 |
UPWK Upwork | $17.00
+1.6% | 11/7/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $14.00 -> $16.00 | N/A | View details for BTIG Research rating of Upwork (NASDAQ:UPWK) on 11/7/2024 |
MELI MercadoLibre | $1,732.76
-0.6% | 11/7/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $2,250.00 -> $2,200.00 | N/A | View details for BTIG Research rating of MercadoLibre (NASDAQ:MELI) on 11/7/2024 |
RVLV Revolve Group | $33.06
-2.2% | 11/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $30.00 -> $35.00 | N/A | View details for BTIG Research rating of Revolve Group (NYSE:RVLV) on 11/6/2024 |
EXAS Exact Sciences | $57.48
-1.1% | 11/6/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $82.00 -> $65.00 | N/A | View details for BTIG Research rating of Exact Sciences (NASDAQ:EXAS) on 11/6/2024 |
CDNA CareDx | $21.44
+0.1% | 11/5/2024 | Target Lowered by | BTIG Research | Analyst M. Massaro | Buy -> Buy | $40.00 -> $35.00 | Low | View details for BTIG Research rating of CareDx (NASDAQ:CDNA) on 11/5/2024 |
TCMD Tactile Systems Technology | $17.79
+2.7% | 11/5/2024 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Buy -> Neutral | | High | View details for BTIG Research rating of Tactile Systems Technology (NASDAQ:TCMD) on 11/5/2024 |
FVRR Fiverr International | $32.74
-1.8% | 11/4/2024 | Downgraded by | BTIG Research | Analyst M. Fong | Buy -> Neutral | | Medium | View details for BTIG Research rating of Fiverr International (NYSE:FVRR) on 11/4/2024 |
WRBY Warby Parker | $25.03
-2.7% | 11/1/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $18.00 -> $20.00 | Low | View details for BTIG Research rating of Warby Parker (NYSE:WRBY) on 11/1/2024 |
IQV IQVIA | $200.25
+0.1% | 11/1/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $290.00 -> $260.00 | Low | View details for BTIG Research rating of IQVIA (NYSE:IQV) on 11/1/2024 |
RBLX Roblox | $59.93
+0.6% | 11/1/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $51.00 -> $56.00 | Low | View details for BTIG Research rating of Roblox (NYSE:RBLX) on 11/1/2024 |
WING Wingstop | $290.85
-0.3% | 10/31/2024 | Upgraded by | BTIG Research | Analyst P. Saleh | Neutral -> Buy | $370.00 | Medium | View details for BTIG Research rating of Wingstop (NASDAQ:WING) on 10/31/2024 |
APP AppLovin | $346.73
+1.4% | 10/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $150.00 -> $202.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 10/30/2024 |
SYK Stryker | $369.42
-0.4% | 10/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $383.00 -> $394.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 10/30/2024 |
TTD Trade Desk | $123.46
-0.4% | 10/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $114.00 -> $142.00 | Low | View details for BTIG Research rating of Trade Desk (NASDAQ:TTD) on 10/30/2024 |
DHI D.R. Horton | $141.47
+0.3% | 10/30/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $190.00 -> $186.00 | Low | View details for BTIG Research rating of D.R. Horton (NYSE:DHI) on 10/30/2024 |
AGYS Agilysys | $138.09
-0.6% | 10/29/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $118.00 -> $124.00 | High | View details for BTIG Research rating of Agilysys (NASDAQ:AGYS) on 10/29/2024 |
BOOT Boot Barn | $155.76
+5.0% | 10/29/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $165.00 -> $185.00 | High | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 10/29/2024 |
NESR National Energy Services Reunited | $8.65
-0.2% | 10/25/2024 | Initiated by | BTIG Research | Analyst G. Lewis | Buy | $15.00 | Medium | View details for BTIG Research rating of National Energy Services Reunited (NASDAQ:NESR) on 10/25/2024 |
TMHC Taylor Morrison Home | $61.25
+0.1% | 10/24/2024 | Target Raised by | BTIG Research | Analyst C. Reichardt | Buy -> Buy | $78.00 -> $86.00 | Low | View details for BTIG Research rating of Taylor Morrison Home (NYSE:TMHC) on 10/24/2024 |
SLP Simulations Plus | $28.78
+1.5% | 10/24/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $60.00 -> $50.00 | High | View details for BTIG Research rating of Simulations Plus (NASDAQ:SLP) on 10/24/2024 |
HLX Helix Energy Solutions Group | $9.27
+0.1% | 10/24/2024 | Downgraded by | BTIG Research | Analyst G. Lewis | Buy -> Neutral | | High | View details for BTIG Research rating of Helix Energy Solutions Group (NYSE:HLX) on 10/24/2024 |
DT Dynatrace | $55.10
+0.1% | 10/23/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $57.00 -> $63.00 | Low | View details for BTIG Research rating of Dynatrace (NYSE:DT) on 10/23/2024 |
ENVA Enova International | $99.61
+1.0% | 10/23/2024 | Target Raised by | BTIG Research | Analyst V. Caintic | Buy -> Buy | $90.00 -> $110.00 | High | View details for BTIG Research rating of Enova International (NYSE:ENVA) on 10/23/2024 |
PHM PulteGroup | $110.65
-0.1% | 10/23/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $139.00 -> $156.00 | Low | View details for BTIG Research rating of PulteGroup (NYSE:PHM) on 10/23/2024 |
CARG CarGurus | $36.88
+0.9% | 10/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $30.00 -> $35.00 | Low | View details for BTIG Research rating of CarGurus (NASDAQ:CARG) on 10/22/2024 |
TRUE TrueCar | $3.93
+1.3% | 10/22/2024 | Target Raised by | BTIG Research | Analyst M. Fong | Buy -> Buy | $3.75 -> $4.50 | Low | View details for BTIG Research rating of TrueCar (NASDAQ:TRUE) on 10/22/2024 |
DECK Deckers Outdoor | $209.43
+0.7% | 10/22/2024 | Downgraded by | BTIG Research | Analyst J. Stichter | Buy -> Neutral | | Low | View details for BTIG Research rating of Deckers Outdoor (NYSE:DECK) on 10/22/2024 |
MSTR MicroStrategy | $341.05
-4.8% | 10/21/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $180.00 -> $240.00 | Medium | View details for BTIG Research rating of MicroStrategy (NASDAQ:MSTR) on 10/21/2024 |
Did You See Trump’s Bombshell Exec. Order 001? (Ad) Starting with what I call Exec. Order 001.
It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office... I put all the details together for you here — but please hurry. |
ISRG Intuitive Surgical | $538.83
+0.3% | 10/18/2024 | Target Set by | BTIG Research | Analyst Ryan Zimmerman | | $535.00 | Medium | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 10/18/2024 |
BIRK Birkenstock | $60.24
+0.1% | 10/18/2024 | Target Set by | BTIG Research | Analyst J. Stichter | Buy -> Buy | $60.00 | Low | View details for BTIG Research rating of Birkenstock (NYSE:BIRK) on 10/18/2024 |
OTLK Outlook Therapeutics | $1.70
+15.6% | 10/18/2024 | Reiterated by | BTIG Research | - | Buy -> Buy | $50.00 -> $50.00 | High | View details for BTIG Research rating of Outlook Therapeutics (NASDAQ:OTLK) on 10/18/2024 |
AURA Aura Biosciences | $8.41
+2.2% | 10/18/2024 | Target Raised by | BTIG Research | Analyst Julian Harrison | Buy -> Buy | $21.00 -> $24.00 | High | View details for BTIG Research rating of Aura Biosciences (NASDAQ:AURA) on 10/18/2024 |
HUMA Humacyte | $5.29
+17.3% | 10/18/2024 | Reiterated by | BTIG Research | Analyst Ryan Zimmerman | Buy -> Buy | $10.00 -> $10.00 | High | View details for BTIG Research rating of Humacyte (NASDAQ:HUMA) on 10/18/2024 |
OKTA Okta | $83.02
-0.2% | 10/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $128.00 -> $98.00 | Low | View details for BTIG Research rating of Okta (NASDAQ:OKTA) on 10/17/2024 |
SBUX Starbucks | $91.86
+2.2% | 10/17/2024 | Target Raised by | BTIG Research | Analyst Peter Saleh | Buy -> Buy | $100.00 -> $115.00 | Low | View details for BTIG Research rating of Starbucks (NASDAQ:SBUX) on 10/17/2024 |
INMD InMode | $17.30
+1.4% | 10/17/2024 | Initiated by | BTIG Research | Analyst M. Thibault | Buy | $25.00 | Low | View details for BTIG Research rating of InMode (NASDAQ:INMD) on 10/17/2024 |
APYX Apyx Medical | $1.60
-9.3% | 10/17/2024 | Initiated by | BTIG Research | Analyst M. Thibault | Neutral | | Medium | View details for BTIG Research rating of Apyx Medical (NASDAQ:APYX) on 10/17/2024 |
AIRS AirSculpt Technologies | $5.64
+3.7% | 10/17/2024 | Initiated by | BTIG Research | Analyst M. Thibault | Neutral | | High | View details for BTIG Research rating of AirSculpt Technologies (NASDAQ:AIRS) on 10/17/2024 |
DHT DHT | $9.32
-1.4% | 10/15/2024 | Initiated by | BTIG Research | Analyst G. Lewis | Buy | $16.00 | Medium | View details for BTIG Research rating of DHT (NYSE:DHT) on 10/15/2024 |
ESTA Establishment Labs | $46.24
+3.9% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $62.00 -> $65.00 | Low | View details for BTIG Research rating of Establishment Labs (NASDAQ:ESTA) on 10/14/2024 |
GMED Globus Medical | $84.42
+1.1% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $77.00 -> $78.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 10/14/2024 |
PODD Insulet | $265.68
+0.9% | 10/14/2024 | Target Raised by | BTIG Research | Analyst M. Thibault | Buy -> Buy | $250.00 -> $260.00 | Medium | View details for BTIG Research rating of Insulet (NASDAQ:PODD) on 10/14/2024 |
ISRG Intuitive Surgical | $538.83
+0.3% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $494.00 -> $518.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 10/14/2024 |
MASI Masimo | $171.02
+1.6% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $166.00 -> $170.00 | Low | View details for BTIG Research rating of Masimo (NASDAQ:MASI) on 10/14/2024 |
PEN Penumbra | $240.54
+0.1% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $224.00 -> $234.00 | Low | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 10/14/2024 |
SYK Stryker | $369.42
-0.4% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $374.00 -> $383.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 10/14/2024 |
ALC Alcon | $86.30
+0.3% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $104.00 -> $106.00 | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 10/14/2024 |
BSX Boston Scientific | $91.45
+0.4% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $84.00 -> $93.00 | Low | View details for BTIG Research rating of Boston Scientific (NYSE:BSX) on 10/14/2024 |
CSTL Castle Biosciences | $27.10
-2.2% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $35.00 -> $40.00 | High | View details for BTIG Research rating of Castle Biosciences (NASDAQ:CSTL) on 10/14/2024 |
DPZ Domino's Pizza | $432.62
+0.4% | 10/11/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $580.00 -> $500.00 | Low | View details for BTIG Research rating of Domino’s Pizza (NYSE:DPZ) on 10/11/2024 |
FOUR Shift4 Payments | $107.10
+1.7% | 10/10/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $90.00 -> $105.00 | Medium | View details for BTIG Research rating of Shift4 Payments (NYSE:FOUR) on 10/10/2024 |
BIRK Birkenstock | $60.24
+0.1% | 10/10/2024 | Initiated by | BTIG Research | Analyst J. Stichter | Buy | $60.00 | High | View details for BTIG Research rating of Birkenstock (NYSE:BIRK) on 10/10/2024 |
CYBR CyberArk Software | $322.46
+0.6% | 10/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $310.00 -> $325.00 | Low | View details for BTIG Research rating of CyberArk Software (NASDAQ:CYBR) on 10/9/2024 |
BLBD Blue Bird | $40.02
+3.0% | 10/9/2024 | Initiated by | BTIG Research | Analyst G. Lewis | Buy | $55.00 | High | View details for BTIG Research rating of Blue Bird (NASDAQ:BLBD) on 10/9/2024 |
AXP American Express | $303.99
+0.2% | 10/8/2024 | Downgraded by | BTIG Research | Analyst V. Caintic | Neutral -> Sell | $230.00 | Medium | View details for BTIG Research rating of American Express (NYSE:AXP) on 10/8/2024 |
AFRM Affirm | $66.85
+1.4% | 10/8/2024 | Upgraded by | BTIG Research | Analyst V. Caintic | Neutral -> Buy | $68.00 | High | View details for BTIG Research rating of Affirm (NASDAQ:AFRM) on 10/8/2024 |
IART Integra LifeSciences | $22.70
+2.6% | 10/7/2024 | Upgraded by | BTIG Research | Analyst R. Zimmerman | Sell -> Neutral | | High | View details for BTIG Research rating of Integra LifeSciences (NASDAQ:IART) on 10/7/2024 |
ZBH Zimmer Biomet | $107.25
0.0% | 10/3/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $134.00 -> $126.00 | Low | View details for BTIG Research rating of Zimmer Biomet (NYSE:ZBH) on 10/3/2024 |
ASTH Astrana Health | $33.53
+0.1% | 10/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $60.00 -> $70.00 | Medium | View details for BTIG Research rating of Astrana Health (NASDAQ:ASTH) on 10/3/2024 |
BTSG BrightSpring Health Services | $17.60
+0.9% | 10/3/2024 | Target Raised by | BTIG Research | Analyst D. Larsen | Buy -> Buy | $15.00 -> $20.00 | Low | View details for BTIG Research rating of BrightSpring Health Services (NASDAQ:BTSG) on 10/3/2024 |
ADPT Adaptive Biotechnologies | $6.44
+0.8% | 10/2/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $7.00 -> $8.00 | Low | View details for BTIG Research rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 10/2/2024 |
NKTR Nektar Therapeutics | $0.95
+4.8% | 9/30/2024 | Reiterated by | BTIG Research | Analyst J. Harrison | Buy | $4.00 | High | View details for BTIG Research rating of Nektar Therapeutics (NASDAQ:NKTR) on 9/30/2024 |
EXPE Expedia Group | $190.12
+0.2% | 9/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $150.00 -> $175.00 | Low | View details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 9/27/2024 |
VRDN Viridian Therapeutics | $19.83
+2.7% | 9/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $56.00 -> $61.00 | Low | View details for BTIG Research rating of Viridian Therapeutics (NASDAQ:VRDN) on 9/26/2024 |
LSPD Lightspeed Commerce | $16.12
+2.9% | 9/26/2024 | Reiterated by | BTIG Research | - | Buy -> Buy | $21.00 -> $21.00 | High | View details for BTIG Research rating of Lightspeed Commerce (NYSE:LSPD) on 9/26/2024 |
GPN Global Payments | $113.76
+0.7% | 9/25/2024 | Downgraded by | BTIG Research | Analyst A. Harte | Buy -> Neutral | | High | View details for BTIG Research rating of Global Payments (NYSE:GPN) on 9/25/2024 |
DRI Darden Restaurants | $188.66
+1.1% | 9/20/2024 | Target Raised by | BTIG Research | Analyst P. Saleh | Buy -> Buy | $175.00 -> $195.00 | Low | View details for BTIG Research rating of Darden Restaurants (NYSE:DRI) on 9/20/2024 |
DASH DoorDash | $170.57
-0.7% | 9/19/2024 | Upgraded by | BTIG Research | Analyst J. Fuller | Neutral -> Buy | $155.00 | Low | View details for BTIG Research rating of DoorDash (NASDAQ:DASH) on 9/19/2024 |
GEHC GE HealthCare Technologies | $79.71
+0.4% | 9/18/2024 | Upgraded by | BTIG Research | Analyst R. Zimmerman | Neutral -> Buy | $100.00 | Low | View details for BTIG Research rating of GE HealthCare Technologies (NASDAQ:GEHC) on 9/18/2024 |
AVAV AeroVironment | $161.50
+0.9% | 9/17/2024 | Reiterated by | BTIG Research | Analyst A. Madrid | Buy -> Buy | $245.00 -> $245.00 | Low | View details for BTIG Research rating of AeroVironment (NASDAQ:AVAV) on 9/17/2024 |
DH Definitive Healthcare | $4.25
+2.9% | 9/17/2024 | Initiated by | BTIG Research | Analyst D. Larsen | Buy | $7.00 | High | View details for BTIG Research rating of Definitive Healthcare (NASDAQ:DH) on 9/17/2024 |
SYF Synchrony Financial | $66.81
+0.3% | 9/16/2024 | Downgraded by | BTIG Research | Analyst V. Caintic | Buy -> Neutral | | Low | View details for BTIG Research rating of Synchrony Financial (NYSE:SYF) on 9/16/2024 |
ALLY Ally Financial | $36.01
+0.7% | 9/16/2024 | Downgraded by | BTIG Research | Analyst V. Caintic | Buy -> Neutral | | Low | View details for BTIG Research rating of Ally Financial (NYSE:ALLY) on 9/16/2024 |
APP AppLovin | $346.73
+1.4% | 9/13/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $114.00 -> $150.00 | High | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 9/13/2024 |
NFE New Fortress Energy | $14.51
+0.1% | 9/13/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $35.00 -> $15.00 | High | View details for BTIG Research rating of New Fortress Energy (NASDAQ:NFE) on 9/13/2024 |
ALC Alcon | $86.30
+0.3% | 9/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $98.00 -> $104.00 | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 9/12/2024 |
RZLT Rezolute | $5.01
+13.6% | 9/10/2024 | Target Raised by | BTIG Research | Analyst J. Harrison | Buy -> Buy | $13.00 -> $15.00 | Low | View details for BTIG Research rating of Rezolute (NASDAQ:RZLT) on 9/10/2024 |
VRDN Viridian Therapeutics | $19.83
+2.7% | 9/10/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $46.00 -> $56.00 | High | View details for BTIG Research rating of Viridian Therapeutics (NASDAQ:VRDN) on 9/10/2024 |
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode before 2025!
Trump could trigger THIS crypto coin…
 YES, I WANT THE #1 CRYPTO NOW |
BOOT Boot Barn | $155.76
+5.0% | 9/10/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $150.00 -> $165.00 | High | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 9/10/2024 |
HAE Haemonetics | $78.85
+1.9% | 9/10/2024 | Initiated by | BTIG Research | Analyst M. Thibault | Buy | $112.00 | Medium | View details for BTIG Research rating of Haemonetics (NYSE:HAE) on 9/10/2024 |
BNGO Bionano Genomics | $0.22
+6.7% | 9/10/2024 | Downgraded by | BTIG Research | Analyst M. Massaro | Buy -> Neutral | | High | View details for BTIG Research rating of Bionano Genomics (NASDAQ:BNGO) on 9/10/2024 |
RBLX Roblox | $59.93
+0.6% | 9/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $47.00 -> $51.00 | High | View details for BTIG Research rating of Roblox (NYSE:RBLX) on 9/9/2024 |
PNST Pinstripes | $0.45
+0.9% | 9/5/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $6.00 -> $4.00 | Low | View details for BTIG Research rating of Pinstripes (NYSE:PNST) on 9/5/2024 |
SOLV Solventum | $66.94
+0.6% | 9/5/2024 | Initiated by | BTIG Research | Analyst R. Zimmerman | Neutral | | Low | View details for BTIG Research rating of Solventum (NYSE:SOLV) on 9/5/2024 |
GTLB GitLab | $59.74
-1.2% | 9/4/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $58.00 -> $63.00 | Low | View details for BTIG Research rating of GitLab (NASDAQ:GTLB) on 9/4/2024 |
ZS Zscaler | $187.63
+0.2% | 9/4/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $220.00 -> $205.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 9/4/2024 |
ATHA Athira Pharma | $0.54
-0.6% | 9/4/2024 | Downgraded by | BTIG Research | Analyst T. Shrader | Buy -> Neutral | | Low | View details for BTIG Research rating of Athira Pharma (NASDAQ:ATHA) on 9/4/2024 |
PCVX Vaxcyte | $85.78
-0.2% | 9/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $98.00 -> $160.00 | Low | View details for BTIG Research rating of Vaxcyte (NASDAQ:PCVX) on 9/3/2024 |
GWRE Guidewire Software | $174.39
-0.1% | 8/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $140.00 -> $165.00 | Low | View details for BTIG Research rating of Guidewire Software (NYSE:GWRE) on 8/30/2024 |
SYK Stryker | $369.42
-0.4% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $360.00 -> $374.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 8/28/2024 |
PEN Penumbra | $240.54
+0.1% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $187.00 -> $224.00 | Low | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 8/28/2024 |
ISRG Intuitive Surgical | $538.83
+0.3% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $469.00 -> $494.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 8/28/2024 |
IART Integra LifeSciences | $22.70
+2.6% | 8/28/2024 | Target Lowered by | BTIG Research | Analyst R. Zimmerman | Sell -> Sell | $22.00 -> $20.00 | Low | View details for BTIG Research rating of Integra LifeSciences (NASDAQ:IART) on 8/28/2024 |
GMED Globus Medical | $84.42
+1.1% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $75.00 -> $77.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 8/28/2024 |
GKOS Glaukos | $152.67
+1.0% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $131.00 -> $139.00 | Low | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 8/28/2024 |
S SentinelOne | $22.84
+0.7% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $28.00 -> $30.00 | Low | View details for BTIG Research rating of SentinelOne (NYSE:S) on 8/28/2024 |
FI Fiserv | $210.29
+0.4% | 8/28/2024 | Initiated by | BTIG Research | Analyst A. Harte | Buy | $200.00 | Low | View details for BTIG Research rating of Fiserv (NYSE:FI) on 8/28/2024 |
QTWO Q2 | $105.68
+0.9% | 8/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $75.00 -> $82.00 | Low | View details for BTIG Research rating of Q2 (NYSE:QTWO) on 8/26/2024 |
FTAI FTAI Aviation | $129.84
+0.4% | 8/26/2024 | Initiated by | BTIG Research | - | Buy | $80.00 -> $140.00 | Low | View details for BTIG Research rating of FTAI Aviation (NYSE:FTAI) on 8/26/2024 |
DNA Ginkgo Bioworks | $10.22
+9.1% | 8/23/2024 | Target Raised by | BTIG Research | Analyst M. Massaro | Sell -> Sell | $0.20 -> $7.00 | Low | View details for BTIG Research rating of Ginkgo Bioworks (NYSE:DNA) on 8/23/2024 |
ALC Alcon | $86.30
+0.3% | 8/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $96.00 -> $98.00 | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 8/22/2024 |
MELI MercadoLibre | $1,732.76
-0.6% | 8/21/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $2,025.00 -> $2,250.00 | Low | View details for BTIG Research rating of MercadoLibre (NASDAQ:MELI) on 8/21/2024 |
CCSI Consensus Cloud Solutions | $24.28
+3.0% | 8/21/2024 | Upgraded by | BTIG Research | Analyst D. Larsen | Neutral -> Buy | $30.00 | Low | View details for BTIG Research rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 8/21/2024 |
PANW Palo Alto Networks | $188.50
-0.5% | 8/20/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $183.00 -> $197.50 | Low | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 8/20/2024 |
LQDA Liquidia | $11.80
+2.3% | 8/19/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $29.00 -> $25.00 | Low | View details for BTIG Research rating of Liquidia (NASDAQ:LQDA) on 8/19/2024 |
CDNA CareDx | $21.44
+0.1% | 8/19/2024 | Upgraded by | BTIG Research | Analyst M. Massaro | Neutral -> Buy | $40.00 | Low | View details for BTIG Research rating of CareDx (NASDAQ:CDNA) on 8/19/2024 |
OS Onestream | $29.43
+1.1% | 8/19/2024 | Initiated by | BTIG Research | Analyst M. Vanvliet | Buy | $37.00 | Low | View details for BTIG Research rating of Onestream (NASDAQ:OS) on 8/19/2024 |
TMHC Taylor Morrison Home | $61.25
+0.1% | 8/19/2024 | Upgraded by | BTIG Research | Analyst C. Reichardt | Neutral -> Buy | $78.00 | Low | View details for BTIG Research rating of Taylor Morrison Home (NYSE:TMHC) on 8/19/2024 |
PSNL Personalis | $6.26
+2.8% | 8/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $5.50 -> $7.00 | Low | View details for BTIG Research rating of Personalis (NASDAQ:PSNL) on 8/16/2024 |
RVLV Revolve Group | $33.06
-2.2% | 8/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $24.00 -> $26.00 | Low | View details for BTIG Research rating of Revolve Group (NYSE:RVLV) on 8/16/2024 |
PYCR Paycor HCM | $19.33
+0.8% | 8/15/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $26.00 -> $20.00 | Low | View details for BTIG Research rating of Paycor HCM (NASDAQ:PYCR) on 8/15/2024 |
FLUT Flutter Entertainment | $259.29
-0.8% | 8/14/2024 | Target Raised by | BTIG Research | Analyst C. Lampen | Buy -> Buy | $245.00 -> $249.00 | Low | View details for BTIG Research rating of Flutter Entertainment (NYSE:FLUT) on 8/14/2024 |
ENVA Enova International | $99.61
+1.0% | 8/14/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $90.00 | Low | View details for BTIG Research rating of Enova International (NYSE:ENVA) on 8/14/2024 |
ZTS Zoetis | $165.52
+0.5% | 8/12/2024 | Target Raised by | BTIG Research | Analyst M. Massaro | Buy -> Buy | $220.00 -> $225.00 | Low | View details for BTIG Research rating of Zoetis (NYSE:ZTS) on 8/12/2024 |
IRT Independence Realty Trust | $20.36
+0.2% | 8/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $18.00 -> $21.00 | Low | View details for BTIG Research rating of Independence Realty Trust (NYSE:IRT) on 8/12/2024 |
CSR Centerspace | $66.42
0.0% | 8/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $69.00 -> $79.00 | Low | View details for BTIG Research rating of Centerspace (NYSE:CSR) on 8/12/2024 |
ADC Agree Realty | $70.81
-0.2% | 8/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $65.00 -> $74.00 | Low | View details for BTIG Research rating of Agree Realty (NYSE:ADC) on 8/12/2024 |
TTD Trade Desk | $123.46
-0.4% | 8/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $110.00 -> $114.00 | Low | View details for BTIG Research rating of Trade Desk (NASDAQ:TTD) on 8/9/2024 |
FIVN Five9 | $42.38
0.0% | 8/9/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $100.00 -> $45.00 | Low | View details for BTIG Research rating of Five9 (NASDAQ:FIVN) on 8/9/2024 |
PODD Insulet | $265.68
+0.9% | 8/9/2024 | Target Lowered by | BTIG Research | Analyst M. Thibault | Buy -> Buy | $270.00 -> $250.00 | Low | View details for BTIG Research rating of Insulet (NASDAQ:PODD) on 8/9/2024 |
CARG CarGurus | $36.88
+0.9% | 8/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $28.00 -> $30.00 | Low | View details for BTIG Research rating of CarGurus (NASDAQ:CARG) on 8/9/2024 |
NTRA Natera | $159.64
-1.7% | 8/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $125.00 -> $135.00 | Low | View details for BTIG Research rating of Natera (NASDAQ:NTRA) on 8/9/2024 |
BMBL Bumble | $8.08
+2.0% | 8/8/2024 | Downgraded by | BTIG Research | Analyst J. Fuller | Buy -> Neutral | | Low | View details for BTIG Research rating of Bumble (NASDAQ:BMBL) on 8/8/2024 |
FLYW Flywire | $20.23
0.0% | 8/7/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $27.00 -> $26.00 | Low | View details for BTIG Research rating of Flywire (NASDAQ:FLYW) on 8/7/2024 |
BL BlackLine | $62.49
+0.2% | 8/7/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $71.00 -> $65.00 | Low | View details for BTIG Research rating of BlackLine (NASDAQ:BL) on 8/7/2024 |
TRIP Tripadvisor | $14.41
| 8/7/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $25.00 -> $20.00 | Low | View details for BTIG Research rating of Tripadvisor (NASDAQ:TRIP) on 8/7/2024 |
IMXI International Money Express | $20.90
+1.0% | 8/7/2024 | Reiterated by | BTIG Research | Analyst A. Harte | Buy -> Neutral | | Low | View details for BTIG Research rating of International Money Express (NASDAQ:IMXI) on 8/7/2024 |
PGNY Progyny | $14.71
+1.2% | 8/7/2024 | Downgraded by | BTIG Research | Analyst D. Larsen | Buy -> Neutral | | Low | View details for BTIG Research rating of Progyny (NASDAQ:PGNY) on 8/7/2024 |
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode before 2025!
Trump could trigger THIS crypto coin…
YES, I WANT THE #1 CRYPTO NOW |
TRUE TrueCar | $3.93
+1.3% | 8/7/2024 | Upgraded by | BTIG Research | Analyst M. Fong | Neutral -> Buy | $3.75 | Low | View details for BTIG Research rating of TrueCar (NASDAQ:TRUE) on 8/7/2024 |
UWMC UWM | $5.84
+1.4% | 8/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $8.00 -> $10.00 | Low | View details for BTIG Research rating of UWM (NYSE:UWMC) on 8/6/2024 |
AKYA Akoya Biosciences | $2.46
+2.1% | 8/6/2024 | Downgraded by | BTIG Research | Analyst M. Massaro | Buy -> Neutral | | Low | View details for BTIG Research rating of Akoya Biosciences (NASDAQ:AKYA) on 8/6/2024 |
MTG MGIC Investment | $24.00
+0.8% | 8/5/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $22.00 -> $25.00 | Low | View details for BTIG Research rating of MGIC Investment (NYSE:MTG) on 8/5/2024 |
ACT Enact | $32.91
+0.4% | 8/5/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $33.00 -> $37.00 | N/A | View details for BTIG Research rating of Enact (NASDAQ:ACT) on 8/5/2024 |
ESNT Essent Group | $54.42
+1.1% | 8/5/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $61.00 -> $64.00 | Low | View details for BTIG Research rating of Essent Group (NYSE:ESNT) on 8/5/2024 |
HWM Howmet Aerospace | $112.53
+0.4% | 8/5/2024 | Target Raised by | BTIG Research | Analyst A. Madrid | Buy -> Buy | $95.00 -> $115.00 | Low | View details for BTIG Research rating of Howmet Aerospace (NYSE:HWM) on 8/5/2024 |
MELI MercadoLibre | $1,732.76
-0.6% | 8/2/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $1,885.00 -> $2,025.00 | Low | View details for BTIG Research rating of MercadoLibre (NASDAQ:MELI) on 8/2/2024 |
PCTY Paylocity | $200.60
-0.3% | 8/2/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $200.00 -> $185.00 | Low | View details for BTIG Research rating of Paylocity (NASDAQ:PCTY) on 8/2/2024 |
VEL Velocity Financial | $19.46
+0.3% | 8/2/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $18.00 -> $20.00 | N/A | View details for BTIG Research rating of Velocity Financial (NYSE:VEL) on 8/2/2024 |
SMRT SmartRent | $1.68
+5.7% | 8/2/2024 | Downgraded by | BTIG Research | Analyst S. Bhonsle | Buy -> Neutral | | Low | View details for BTIG Research rating of SmartRent (NYSE:SMRT) on 8/2/2024 |
CVNA Carvana | $224.06
+0.1% | 8/1/2024 | Target Raised by | BTIG Research | Analyst M. Fong | Buy -> Buy | $155.00 -> $188.00 | Low | View details for BTIG Research rating of Carvana (NYSE:CVNA) on 8/1/2024 |
DRS Leonardo DRS | $33.07
+0.2% | 8/1/2024 | Target Raised by | BTIG Research | Analyst A. Madrid | Buy -> Buy | $30.00 -> $33.00 | Low | View details for BTIG Research rating of Leonardo DRS (NASDAQ:DRS) on 8/1/2024 |
QTWO Q2 | $105.68
+0.9% | 8/1/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $60.00 -> $75.00 | Low | View details for BTIG Research rating of Q2 (NYSE:QTWO) on 8/1/2024 |
MGNX MacroGenics | $3.26
| 8/1/2024 | Downgraded by | BTIG Research | Analyst K. Pohlman | Buy -> Neutral | | Low | View details for BTIG Research rating of MacroGenics (NASDAQ:MGNX) on 8/1/2024 |
DDOG Datadog | $147.56
-0.6% | 8/1/2024 | Upgraded by | BTIG Research | Analyst G. Powell | Neutral -> Buy | $143.00 | Low | View details for BTIG Research rating of Datadog (NASDAQ:DDOG) on 8/1/2024 |
WGS GeneDx | $79.45
+2.6% | 7/31/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $35.00 -> $45.00 | Low | View details for BTIG Research rating of GeneDx (NASDAQ:WGS) on 7/31/2024 |
ATRC AtriCure | $30.75
+0.8% | 7/31/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $58.00 -> $53.00 | Low | View details for BTIG Research rating of AtriCure (NASDAQ:ATRC) on 7/31/2024 |
PEN Penumbra | $240.54
+0.1% | 7/31/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $232.00 -> $187.00 | Low | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 7/31/2024 |
SYK Stryker | $369.42
-0.4% | 7/31/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $372.00 -> $360.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 7/31/2024 |
AOMR Angel Oak Mortgage REIT | $9.40
+1.0% | 7/31/2024 | Initiated by | BTIG Research | Analyst E. Hagen | Buy | $13.50 | Low | View details for BTIG Research rating of Angel Oak Mortgage REIT (NYSE:AOMR) on 7/31/2024 |
GH Guardant Health | $31.37
-0.6% | 7/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $45.00 -> $50.00 | Low | View details for BTIG Research rating of Guardant Health (NASDAQ:GH) on 7/30/2024 |
CRS Carpenter Technology | $175.64
+0.6% | 7/30/2024 | Target Raised by | BTIG Research | Analyst A. Madrid | Buy -> Buy | $120.00 -> $165.00 | Low | View details for BTIG Research rating of Carpenter Technology (NYSE:CRS) on 7/30/2024 |
IART Integra LifeSciences | $22.70
+2.6% | 7/30/2024 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Neutral -> Sell | $22.00 | Low | View details for BTIG Research rating of Integra LifeSciences (NASDAQ:IART) on 7/30/2024 |
TXRH Texas Roadhouse | $182.54
0.0% | 7/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $175.00 -> $190.00 | Low | View details for BTIG Research rating of Texas Roadhouse (NASDAQ:TXRH) on 7/26/2024 |
TYL Tyler Technologies | $592.84
-1.1% | 7/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $550.00 -> $630.00 | Low | View details for BTIG Research rating of Tyler Technologies (NYSE:TYL) on 7/26/2024 |
DXCM DexCom | $80.57
+0.4% | 7/26/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $156.00 -> $120.00 | Low | View details for BTIG Research rating of DexCom (NASDAQ:DXCM) on 7/26/2024 |
ZTS Zoetis | $165.52
+0.5% | 7/25/2024 | Initiated by | BTIG Research | Analyst M. Massaro | Buy | $220.00 | Low | View details for BTIG Research rating of Zoetis (NYSE:ZTS) on 7/25/2024 |
IDXX IDEXX Laboratories | $417.11
+0.8% | 7/25/2024 | Initiated by | BTIG Research | Analyst M. Massaro | Buy | $580.00 | Low | View details for BTIG Research rating of IDEXX Laboratories (NASDAQ:IDXX) on 7/25/2024 |
PTGX Protagonist Therapeutics | $39.51
+0.5% | 7/24/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $41.00 -> $51.00 | Low | View details for BTIG Research rating of Protagonist Therapeutics (NASDAQ:PTGX) on 7/24/2024 |
PHM PulteGroup | $110.65
-0.1% | 7/24/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $133.00 -> $139.00 | Low | View details for BTIG Research rating of PulteGroup (NYSE:PHM) on 7/24/2024 |
EXPI eXp World | $11.96
+1.2% | 7/23/2024 | Upgraded by | BTIG Research | Analyst S. Bhonsle | Sell -> Neutral | | Low | View details for BTIG Research rating of eXp World (NASDAQ:EXPI) on 7/23/2024 |
STC Stewart Information Services | $70.34
+0.1% | 7/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $68.00 -> $80.00 | Low | View details for BTIG Research rating of Stewart Information Services (NYSE:STC) on 7/22/2024 |
CRWD CrowdStrike | $365.08
-0.2% | 7/22/2024 | Downgraded by | BTIG Research | Analyst G. Powell | Buy -> Neutral | | Low | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 7/22/2024 |
AGYS Agilysys | $138.09
-0.6% | 7/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $95.00 -> $118.00 | Low | View details for BTIG Research rating of Agilysys (NASDAQ:AGYS) on 7/19/2024 |
FOR Forestar Group | $26.19
+0.7% | 7/19/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $41.00 -> $37.00 | Low | View details for BTIG Research rating of Forestar Group (NYSE:FOR) on 7/19/2024 |
ARI Apollo Commercial Real Estate Finance | $9.06
-0.3% | 7/19/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Apollo Commercial Real Estate Finance (NYSE:ARI) on 7/19/2024 |
CMTG Claros Mortgage Trust | $4.32
+1.6% | 7/19/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Claros Mortgage Trust (NYSE:CMTG) on 7/19/2024 |
RC Ready Capital | $7.35
-0.5% | 7/19/2024 | Initiated by | BTIG Research | Analyst S. Barcomb | Strong-Buy -> Neutral | | Low | View details for BTIG Research rating of Ready Capital (NYSE:RC) on 7/19/2024 |
ACRE Ares Commercial Real Estate | $6.22
-1.4% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Neutral | | Low | View details for BTIG Research rating of Ares Commercial Real Estate (NYSE:ACRE) on 7/19/2024 |
BRSP BrightSpire Capital | $5.95
-0.3% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Neutral | | Low | View details for BTIG Research rating of BrightSpire Capital (NYSE:BRSP) on 7/19/2024 |
BXMT Blackstone Mortgage Trust | $18.12
-0.9% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $23.00 | Low | View details for BTIG Research rating of Blackstone Mortgage Trust (NYSE:BXMT) on 7/19/2024 |
FBRT Franklin BSP Realty Trust | $12.75
-0.3% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $16.00 | Low | View details for BTIG Research rating of Franklin BSP Realty Trust (NYSE:FBRT) on 7/19/2024 |
KREF KKR Real Estate Finance Trust | $10.40
-1.5% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $11.50 | Low | View details for BTIG Research rating of KKR Real Estate Finance Trust (NYSE:KREF) on 7/19/2024 |
LADR Ladder Capital | $11.41
-0.3% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $13.50 | Low | View details for BTIG Research rating of Ladder Capital (NYSE:LADR) on 7/19/2024 |
STWD Starwood Property Trust | $19.41
-0.5% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $24.00 | Low | View details for BTIG Research rating of Starwood Property Trust (NYSE:STWD) on 7/19/2024 |
TRTX TPG RE Finance Trust | $8.72
-0.6% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $11.00 | Low | View details for BTIG Research rating of TPG RE Finance Trust (NYSE:TRTX) on 7/19/2024 |
RZLT Rezolute | $5.01
+13.6% | 7/17/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $13.00 | Low | View details for BTIG Research rating of Rezolute (NASDAQ:RZLT) on 7/17/2024 |
VCEL Vericel | $57.67
+0.6% | 7/15/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $56.00 -> $55.00 | Low | View details for BTIG Research rating of Vericel (NASDAQ:VCEL) on 7/15/2024 |
SYK Stryker | $369.42
-0.4% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $369.00 -> $372.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 7/15/2024 |
STAA STAAR Surgical | $24.60
-1.5% | 7/15/2024 | Target Raised by | BTIG Research | Analyst R. Zimmerman | Buy -> Buy | $46.00 -> $53.00 | Low | View details for BTIG Research rating of STAAR Surgical (NASDAQ:STAA) on 7/15/2024 |
RXST RxSight | $35.05
+1.7% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $72.00 -> $73.00 | Low | View details for BTIG Research rating of RxSight (NASDAQ:RXST) on 7/15/2024 |
PEN Penumbra | $240.54
+0.1% | 7/15/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $265.00 -> $232.00 | Low | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 7/15/2024 |
ISRG Intuitive Surgical | $538.83
+0.3% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $451.00 -> $459.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 7/15/2024 |
HUMA Humacyte | $5.29
+17.3% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $8.00 -> $11.00 | Low | View details for BTIG Research rating of Humacyte (NASDAQ:HUMA) on 7/15/2024 |
GMED Globus Medical | $84.42
+1.1% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $72.00 -> $75.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 7/15/2024 |
GKOS Glaukos | $152.67
+1.0% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $112.00 -> $131.00 | Low | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 7/15/2024 |
BSX Boston Scientific | $91.45
+0.4% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $80.00 -> $84.00 | Low | View details for BTIG Research rating of Boston Scientific (NYSE:BSX) on 7/15/2024 |
ALC Alcon | $86.30
+0.3% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $92.00 -> $96.00 | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 7/15/2024 |
CVNA Carvana | $224.06
+0.1% | 7/12/2024 | Initiated by | BTIG Research | Analyst M. Fong | Buy | $155.00 | Low | View details for BTIG Research rating of Carvana (NYSE:CVNA) on 7/12/2024 |
